| Catalog Number |
08836981190 |
| Medical Device Problem Code |
False Positive Result (1227)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
09/25/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
The serial number of the customer's e411 analyzer is (b)(6).The serial number of the e411 analyzer used for investigation is unknown.The investigation is ongoing.
|
| |
|
Event or Problem Description
|
|
The initial reporter stated they received discrepant results for one patient sample tested with elecsys anti-hcv ii on two cobas e411 analyzers.The sample was first tested on the customer's e411 analyzer, resulting in anti-hcv values of 0.916 coi (borderline) and 0.926 coi (borderline).The sample was provided for investigation where it was tested on a second e411 analyzer, resulting in anti-hcv values of 0.952 coi (borderline) and 0.964 coi (borderline).The sample was tested using an unknown clia method, resulting in an anti-hcv value of 0.65 (negative).The specific unit of measure is not known.The sample was tested using the fujirebio hcv score assay, resulting in a borderline anti-hcv value (c2: 1+).
|
| |
|
Additional Manufacturer Narrative
|
|
The investigation determined that a sample specific issue is likely.The elecsys anti-hcv ii assay performs within specification.All initially reactive samples should be re-determined in duplicate with the elecsys ahcvii assay.Repeatedly reactive samples are confirmed via supplemental methods (e.G.Immunoblot or detection of hcv rna).If one or both measurements remain borderline, the analysis of a follow-up sample is recommend.For diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings.
|
| |
|
Search Alerts/Recalls
|